sitafloxacin: Clinical Trials

7 trials of sitafloxacin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 completed, 1 enrolling by invitation, 1 not yet recruiting. 4 Phase 3, 3 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 34Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 23Unknown 2, Enrolling by invitation 1
Phase 41Completed 1

Follow sitafloxacin: new trials by email Literature Review of sitafloxacin trials Research Report on sitafloxacin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ultra-Short Regimen for Elderly DS-TB
Bedaquiline (B), Sitafloxacin (S), Linezolid (L) - Pulmonary Tuberculosis
Phase 3Not yet recruitingShenzhen Third People's Hospital3002025-07-252025-07-22
A PAN-USR TB Multi-Center Trial
Bedaquiline (B), Sitafloxacin (S), Linezolid (L) - Pulmonary Tuberculosis
Phase 3RecruitingShenzhen Third People's Hospital6102025-06-182025-12-01
Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease
Sitafloxacin - Fluoroquinolone, Mycobacterium
Phase 2Enrolling by invitationBeijing Chest Hospital122025-01-282025-02-05
Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment
Sitafloxacin, SMZ/TMP, Rifampin - Tuberculosis, Pulmonary
Phase 3UnknownFirst Affiliated Hospital of Zhejiang University6202022-10-012022-07-12
A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Sitafloxacin, Moxifloxacin Hydrochloride - COPD Exacerbation Acute
Phase 4CompletedDaiichi Sankyo1402022-08-102025-01-09
Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients
Sitafloxacin, Ertapenem - Anti-Infective Agents, Urinary, Escherichia Coli Infections
Phase 2 / Phase 3UnknownKhon Kaen University302016-07-012023-03-08
Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli
Sitafloxacin, Ertapenem - Infection Due to Escherichia Coli, Acute Pyelonephritis
Phase 2UnknownMahidol University962012-11-012015-09-02

Conditions studied

Tuberculosis, Pulmonary (3)  ·  Escherichia coli Infections (2)  ·  Klebsiella Infections (1)  ·  Mycobacterium Infections (1)  ·  Mycobacterium Infections, Nontuberculous (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Urinary Tract Infections (1)

Sponsors

Shenzhen Third People's Hospital (2)  ·  Beijing Chest Hospital (1)  ·  Daiichi Sankyo (1)  ·  First Affiliated Hospital of Zhejiang University (1)  ·  Khon Kaen University (1)  ·  Mahidol University (1)

Countries

China (3)  ·  Thailand (2)

Top investigators

Sasisopin Kiertiburanakul (1)

Results publications

PMID 36808186, PMID 26038418, PMID 26104205, PMID 36053506, PMID 36546625, PMID 37567554, PMID 37980911